← Eichor
Study identifier: NCT06142929 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence

Condition: Dupuytren's Disease  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Dupuytren disease (DD) is a highly prevalent disabling hand disease. Spontaneous fibrosis nodules and strands in the palms of the hand cause finger contractures in disturbing positions and movement restrictions. Finger movement can be restored by surgery (removing the fibrosis tissue), but recurrence is a major problem and this is difficult to treat. Through microfasciectomy, the presence of small nerve bundles (micronerves) were observed. These nerves are possibly related to the hand fascia, which is the origin of Dupuytren disease. These micornerves and their dissection could play a role in the recurrence of DD. This study will investigate the role of these micronerves in DD, the impact of its dissection on formation of neuromas and on recurrence. Also, the presence of nerve growth factor (NGF) will be evaluated. The purpose is to provide information on potential neuro-induced fibrosis.

This description comes directly from the study's public registry record.

Talk to the study team

Ilse Degreef, Prof. Dr.  ·  +32 16 33 88 43  ·  ilse.degreef@uzleuven.be

Anna Tarasiuk  ·  +32 16 33 88 18  ·  orthopedie.research@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

Universitaire Ziekenhuizen KU LeuvenLeuven, Vlaams-Brabant, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06142929